Table 2. The risk factors for NAFLD.

Risk Factor		Univariate			Multivariate
		OR	p *	95% CI	OR	p †	95% CI
BMI (kg/m2)
	≥ 25	3.526	< 0.001	1.780–6.985	2.270	0.047	1.012–5.093
	< 25
Menopause		0.760	0.430	0.380–1.520
Pre-menopause
Waist (cm)
	≥ 80	6.111	< 0.001	2.407–15.518	4.138	0.009	1.428–11.992
	< 80
Cholesterol (mg/dL)
	≥ 200	1.253	0.462	0.654–2.402
	< 200
Triglyceride (mg/dL)
	≥ 150	2.793	0.003	1.405–5.551	2.253	0.036	1.054–4.865
	< 150
HDL-C (mg/dL)
	≤ 50	2.245	0.016	1.158–4.355	1.295	0.521	0.587–2.858
	> 50
LDL-C (mg/dL)
	≥ 150	0.491	0.040	0.248–0.974	0.309	0.005	0.137–0.697
	< 150
Fasting glucose (mg/dL)
	≥ 100	0.970	0.93	0.489–1.924
	< 100
Hypertension
	Yes	1.213	0.561	0.633–2.325
	No
Hormone treatment
	Tam
	AI	0.695	0.309	0.344–1.404
Hormone treatment
	Tam
	Tam + AI	0.825	0.424	0.338–2.012

NAFLD = non-alcoholic fatty liver disease; OR = odd ratio; CI = confidence interval; BMI = body mass index; HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; Tam = tamoxifen; AI = aromatase inhibitor; Tam + AI = tamoxifen for 2 years followed by AI.

^*Footnote mark is calculated with Pearson χ² test; ^†calculated by regression logistic, method backward LR; p < 0.05 is considered as statistically significant (bold-faced).